TINOS THERAPEUTICS
Live / Applied — Third extension granted (statement of use) (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 01 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97914745
- Mark type
- Stylized text
- Filed
- 01 May 2023
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)
Owner
- Tinos Therapeutics, Inc., Barrington, RI, US
- Tinos Therapeutics, Inc., Barrington, RI, US
Prosecution history
- 05 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 3 GRANTED
- 04 Mar 2026 — SOU EXTENSION 3 FILED
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2025 — SOU EXTENSION 2 GRANTED
- 05 Sept 2025 — SOU EXTENSION 2 FILED
- 05 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2025 — SOU EXTENSION 1 GRANTED
- 10 Mar 2025 — SOU EXTENSION 1 FILED
- 10 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION